| 000 | 01713 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517025846.0 | ||
| 264 | 0 | _c20160229 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2015.04.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeng, Guang | |
| 245 | 0 | 0 |
_aDaidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cJun 2015 |
||
| 300 |
_a392-400 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcute Lung Injury _xchemically induced |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xmetabolism |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aIsoflavones _xadministration & dosage |
| 650 | 0 | 4 |
_aLipopolysaccharides _ximmunology |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNF-kappa B _xgenetics |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPeroxidase _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aToll-Like Receptor 4 _xmetabolism |
| 700 | 1 | _aSun, Bo | |
| 700 | 1 | _aLi, Tian-zuo | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 26 _gno. 2 _gp. 392-400 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2015.04.002 _zAvailable from publisher's website |
| 999 |
_c24817710 _d24817710 |
||